India Demonstrates Strong Market Potential with Rising Obesity Prevalence Revenue from obesity GLP-1 treatment in India is expanding at a CAGR of 28.4%, supported by increasing obesity rates in metropolitan areas and growing awareness of cardiovascular risk factors
We summarize advances in research on urate -lowering drugs including urate transporter inhibitors, xanthine oxidase inhibitors as well as novel urate -lowering drugs, and evaluate the effect of urate-lowering therapy on the rate of hyperuricaemia-related diseases
Aim for a temperature between 36F and 46F (2C to 8C)
Beneficial effects are evident across the continuum of human movement, from breaking prolonged sitting with light activity [103] to high-intensity interval training [123]
Novel nucleic acid nanocomplexes, such as CpG-STAT3 siRNA conjugates (NCT04995536), were evaluated for their ability to silence oncogenic pathways and stimulate immune responses in relapsed B-cell non-Hodgkin lymphoma (NHL), although the study was withdrawn before completion